Scarica l'app Stockscreener
149.42
0.60%
-0.80
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BDX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$150.22
Aprire:
$150.84
Volume 24 ore:
594.34K
Relative Volume:
0.23
Capitalizzazione di mercato:
$42.50B
Reddito:
$21.92B
Utile/perdita netta:
$1.76B
Rapporto P/E:
24.41
EPS:
6.1223
Flusso di cassa netto:
$2.63B
1 W Prestazione:
-4.71%
1M Prestazione:
-3.36%
6M Prestazione:
-18.94%
1 anno Prestazione:
-27.03%
Intervallo 1D:
$148.40
$151.85
Intervallo di 1 settimana:
$148.40
$157.66
Portata 52W:
$148.40
$213.08
Becton Dickinson Co Stock (BDX) Company Profile
Nome
Becton Dickinson Co
Settore
Industria
Telefono
(201) 847-6800
Indirizzo
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
149.39 | 42.73B | 21.92B | 1.76B | 2.63B | 6.1223 |
ISRG
Intuitive Surgical Inc
|
466.74 | 166.81B | 10.58B | 3.00B | 2.83B | 8.2437 |
MDLN
Medline Inc
|
44.38 | 38.25B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
75.37 | 37.05B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
217.91 | 32.34B | 5.40B | 1.49B | 1.78B | 10.12 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-10 | Ripresa | Goldman | Neutral |
| 2026-02-10 | Ripresa | Barclays | Overweight |
| 2026-02-03 | Ripresa | Citigroup | Buy |
| 2025-09-25 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-02 | Downgrade | Goldman | Buy → Neutral |
| 2025-05-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-07-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-05-05 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Sell → Neutral |
| 2022-07-11 | Downgrade | Citigroup | Neutral → Sell |
| 2022-06-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | Ripresa | Raymond James | Mkt Perform |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-12-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-06-01 | Ripresa | Goldman | Buy |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-07 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-02-07 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-01-08 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-05-13 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-12-07 | Iniziato | Deutsche Bank | Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-06-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-04-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-01-19 | Ripresa | BofA/Merrill | Buy |
| 2018-01-05 | Aggiornamento | Citigroup | Sell → Neutral |
| 2018-01-05 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2017-12-29 | Reiterato | Deutsche Bank | Buy |
Mostra tutto
Becton Dickinson Co Borsa (BDX) Ultime notizie
Becton Dickinson (NYSE: BDX) CRO sells 74 common shares in market trade - Stock Titan
Becton Dickinson & Co. stock underperforms Monday when compared to competitors - MarketWatch
Transforming Becton, Dickinson and Company’s global integration landscape - Capgemini
Piper Sandler Trims Becton Dickinson (BDX) PT on Model Revisions - Yahoo Finance
Becton Dickinson & Co. stock underperforms Friday when compared to competitors - MarketWatch
Becton Dickinson and Company (BDX): Gold Standard Defensive Stock - Yahoo Finance
XS276302639 Bond Price and Chart — DUS:XS276302639 - TradingView
Kanawha Capital Management LLC Sells 13,557 Shares of Becton, Dickinson and Company $BDX - MarketBeat
KLP Kapitalforvaltning AS Acquires 65,500 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Stake Reduced by Boston Trust Walden Corp - MarketBeat
TABR Capital Management LLC Makes New $3.81 Million Investment in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Ticino Wealth Takes $1.48 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Khaitan, Clifford Chance act on Becton Dickinson’s global spin-off of its biosciences and diagnostic solut.. - ETLegalWorld.com
Becton Dickinson and Co stock (US0758871091): Is its medtech diversification strong enough for stead - AD HOC NEWS
Deals tracker: Community Health Systems adds surgery centers - Modern Healthcare
What You Need to Know Ahead of Becton, Dickinson and Company's Earnings Release - Yahoo Finance
Becton, Dickinson and Company (BDX) Stock Analysis: A Look at Its 20.77% Potential Upside - DirectorsTalk Interviews
Busey Bank Decreases Position in Becton, Dickinson and Company $BDX - MarketBeat
Lobbying Update: $60,000 of BECTON DICKINSON AND COMPANY lobbying was just disclosed - Quiver Quantitative
Becton Dickinson Stock Offers Stability and Dividends for Investors - HarianBasis.co
RBC Capital Lowers Becton Dickinson Price Target to $175 - HarianBasis.co
KANAWHA CAPITAL MANAGEMENT LLC's Becton Dickinson & Co(BDX) Holding History - GuruFocus
Becton Dickinson & Co stock (US0758871091): Why Google Discover visibility now matters more for medt - AD HOC NEWS
Slocum Gordon & Co LLP Makes New $1.94 Million Investment in Becton, Dickinson and Company $BDX - MarketBeat
KBC Group NV Has $14.85 Million Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson Wins Supply Chain Honors As Valuation Appears Undemanding - Yahoo Finance
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
The Healthcare Stock Built for Investors Who Prioritize Capital Preservation - The Motley Fool
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $159 - 富途牛牛
Only one medical supplier won all 3 new HIRC awards: BD - Stock Titan
Assetmark Inc. Boosts Holdings in Becton, Dickinson and Company $BDX - MarketBeat
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $175 - 富途牛牛
Third View Private Wealth LLC Takes $4.99 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Stock Holdings Lessened by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Becton, Dickinson and Company’s Bilal Muhsin on the future of Connected Care - Gulf Business
Becton Dickinson And Co: A $5.3 Billion Quarter Signals Limited Growth Momentum - Smartkarma
Massachusetts Financial Services Co. MA Has $1.84 Billion Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Goldman Sachs Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $167 - 富途牛牛
Cardinal Capital Management Inc. Has $23.89 Million Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company (BD) 8-K Filing April 2026 – Company Details, Registered Securities, and Contact Information - Minichart
Becton, Dickinson and Company (BDX) Announces Executive Retireme - GuruFocus
Rick Byrd to Retire from BD - Finviz
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Richard E. Byrd to Retire as President of Interventional at Becton Dickinson - TradingView
After 25 years at BD, a top medical device executive will retire - Stock Titan
Becton, Dickinson and Company (BDX) Stock Price, News, Quote & History - Yahoo! Finance Canada
For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD PureWick Urine Collection System - Finviz
OFI Invest Asset Management Grows Position in Becton, Dickinson and Company $BDX - MarketBeat
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $202 - 富途牛牛
Becton Dickinson & Co. stock rises Wednesday, still underperforms market - MarketWatch
Becton Dickinson Co Azioni (BDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):